Mental health counselors work in a meaningful and stimulating profession with a tremendously diverse knowledge domain. On one hand, it’s exciting to know that there is no limit to what a counselor can learn. On the other hand, it’s challenging to keep up with such a complex and expansive profession, especially in a mental healthcare system that is rapidly evolving.
Live Events: Keep calm and register for a webinar! FMHCA has lined up another qualified panel of experts in a range of relevant topics so that you can keep updated with our rapidly evolving profession. Attendance is FREE to FMHCA members as a new benefit of membership, and CEUs will be available at a nominal cost of $10 for FMHCA members or $30 for nonmembers. Not a member? You can join now Click Here
Members Only Webinar Archives: Because FMHCA records all of our webinars we are able to offer the recordings to our members for FREE. If you just want to learn more about a topic or take a refresher, watch a free webinar without worrying about the CEs. Click here to go to the members only webinar archives.
Session 13: Addressing Tobacco Use in Behavioral Health
Date: Friday, 12/8/17, 2:00-4:00 pm
Presenter: Andree Aubrey, MSW, LCSW, CCTS
Description: Tobacco is the leading cause of preventable deaths in the US and causes more deaths than the primary behavioral disorder in people with behavioral health conditions. Behavioral health clinicians are uniquely positioned to impact this problem which has largely been unresponsive to traditional state tobacco control programs and policies. In this webinar, clinicians will learn brief and intensive evidence based interventions for tobacco users who are ambivalent about quitting, review guideline based counseling interventions and discuss seven FDA medications which double the livelihood of success. We will review emerging literature which indicates improvements in mental health with abstinence from tobacco and indicates modest improvements or at least no harm for tobacco cessation during recovery from other addictive substances.